Daniel Lang is Chief Investment Officer of the RS Value team. RS Investments was acquired by Victory Capital in July 2016 and is a Victory Capital investment franchise.
Mr. Lang began his investment career in 2001. Prior to joining RS Investments in 2009, he was a portfolio manager at Farallon Capital Management covering the global biotechnology, medical device, pharmaceutical, and health care services industries. Previously, he was a senior associate at venture capital firm Brilleon Capital US and the co-founder and CFO of Sapient Medical Group. Mr. Lang’s business and investment experience was preceded by a distinguished career practicing medicine. He was a fellow in cardiology and a post-doctoral research fellow at the University of California, San Francisco. Additionally, he was board certified in internal medicine and served as a chief medical resident at Mount Sinai Hospital in New York.
Mr. Lang holds a B.A. in chemistry from Cornell University and an M.D. from Cornell University Medical College.